The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2024Measurement of Phosphorylated Alpha-synuclein in Skin Biopsies as a Prospective Biomarker for Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is associated with an accumulation of phosphorylated alpha-synuclein, and the amount of the protein increases as PD progresses. We have found that we can...
-
Research Grant, 2024Developing Community Health Worker Remote Training Modules on Research, Brain Health and Parkinson’s Disease
Study Rationale: Neurodegenerative diseases including Parkinson's disease (PD) disproportionately impact underserved communities due to barriers in research participation and awareness. Community...
-
ASAP 2020, 2024Parkinson5D: Deconstructing Disease Mechanisms Across Cells, Space and Disease Progression
Study Rationale: Genome-wide association studies (GWAS) have unequivocally linked thousands of genetic variants to susceptibility for common, genetically complex Parkinson’s disease (PD), which...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Investigating Oxygen Limitation (Hypoxia) as a Novel Treatment for Parkinson’s Disease
Study Rationale: Non-pharmacological interventions can benefit human health, and anecdotal evidence suggest that people with Parkinson’s disease (PD) show fewer symptoms when traveling at high...
-
Research Grant, 2024Planning for a Dynamic Microsimulation Model of the Health and Financial Effects of Parkinson’s Disease
Study Rationale: As new treatments for Parkinson's disease (PD) are developed, it is important to determine how they might affect the health and finances of people with PD, their families and society...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2024Evaluating the Neuroprotective Factor REST as a Target for Parkinson’s Disease
Study Rationale: Studies have shown that a regulatory factor called REST could promote the survival of neurons in neurodegenerative conditions. This factor is produced in greater quantities with age...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.